Aggressive Patterns on Your Pathology Report

When you receive a pathology report for prostate cancer, the most common term you will see is acinar adenocarcinoma. This is the standard form of the disease. However, for some men—particularly those with a family history or a BRCA2 mutation—the report may contain specific terms that describe a more aggressive “look” to the cancer cells ^[1][2].

Identifying Aggressive Patterns

Pathologists look at how the cancer cells grow and organize themselves. Three specific patterns are highly significant for your prognosis:

1. Intraductal Carcinoma of the Prostate (IDC-P)

In IDC-P, malignant cells are seen occupying the existing ducts of the prostate ^[3].

• Significance: Unlike early-stage diseases in other organs (like DCIS in breast cancer), prostate IDC-P is rarely an isolated pre-invasive condition. Instead, it almost always indicates that aggressive, high-grade invasive cancer cells have spread backwards and are occupying the ducts ^[4][5]. It is a very strong signal that the cancer is highly aggressive and likely to spread if not treated promptly.
• The BRCA2 Link: IDC-P is frequently found in men who carry BRCA2 germline mutations ^[2].

2. Cribriform Morphology

The word cribriform comes from the Latin word for “sieve.” Under a microscope, these cancer cells look like a piece of Swiss cheese with many small holes ^[6].

• Significance: The presence of a cribriform pattern is an independent “red flag.” Even if your overall Gleason score is mid-range, having this specific pattern increases the risk of the cancer returning after surgery or spreading to lymph nodes ^[7][8].

3. Ductal Adenocarcinoma

While most prostate cancer comes from the small glands (acinar), ductal adenocarcinoma arises from the larger ducts ^[9].

• Significance: This is a rare but very aggressive subtype. It is often found mixed with common prostate cancer but tends to grow and spread faster than the acinar type ^[10][11].

Why These Patterns Matter

If your report mentions any of these three terms, it tells your doctor that the “biological engine” of your cancer may be more powerful than a typical case.

• Prognosis: These features are associated with a higher risk of biochemical recurrence (PSA rising after treatment) and a higher likelihood of the cancer already being metastatic at the time of diagnosis ^[7][2].
• Treatment Decisions: Many doctors believe the presence of IDC-P or cribriform patterns makes a patient a poor candidate for active surveillance, even if the rest of the report looks “low-risk” ^[12][5].

Your Pathology Report Checklist

You have the right to “audit” your report. Check for these specific entries, and if you don’t see them, ask your doctor if they were specifically looked for:

• [ ] Morphology: Does it mention “Cribriform architecture”?
• [ ] Intraductal: Is “Intraductal carcinoma (IDC-P)” present or absent?
• [ ] Subtype: Is there any mention of “Ductal adenocarcinoma” (not to be confused with intraductal)?
• [ ] Gleason Grade: Are these patterns factored into your Gleason score (they are almost always considered Grade 4 or 5) ^[13]?
• [ ] Genetic Referral: Does the presence of these patterns warrant a referral for germline testing for BRCA2 or other DNA repair mutations ^[14][15]?

Understanding these terms allows you to move past the simple “cancer” diagnosis and talk to your team about the specific biology of your disease.